|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
3
|
|
pubmed:dateCreated |
1996-10-17
|
|
pubmed:abstractText |
It has been suggested that overuse of fenoterol metered-dose inhalers (MDIs) may increase the risk of death from asthma due to cardiac arrhythmias. Our primary objective was to compare the cardiovascular safety of fenoterol and albuterol MDIs when administered in maximal bronchodilating or maximal tolerated doses to an absolute maximum of 16 puffs, for the emergency department (ED) treatment of acute severe asthma.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Sep
|
|
pubmed:issn |
0012-3692
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
110
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
595-603
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:8797398-Acute Disease,
pubmed-meshheading:8797398-Administration, Inhalation,
pubmed-meshheading:8797398-Adolescent,
pubmed-meshheading:8797398-Adrenergic beta-Agonists,
pubmed-meshheading:8797398-Adult,
pubmed-meshheading:8797398-Albuterol,
pubmed-meshheading:8797398-Asthma,
pubmed-meshheading:8797398-Double-Blind Method,
pubmed-meshheading:8797398-Female,
pubmed-meshheading:8797398-Fenoterol,
pubmed-meshheading:8797398-Forced Expiratory Volume,
pubmed-meshheading:8797398-Humans,
pubmed-meshheading:8797398-Male,
pubmed-meshheading:8797398-Middle Aged,
pubmed-meshheading:8797398-Treatment Outcome
|
|
pubmed:year |
1996
|
|
pubmed:articleTitle |
Cardiovascular safety of high doses of inhaled fenoterol and albuterol in acute severe asthma.
|
|
pubmed:affiliation |
McMaster University, Hamilton, Ontario, Canada.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't,
Multicenter Study
|
